Medical cannabis is a massively growing market in Europe – but it is not classified or regulated within the usual framework for medicines. There is…
The cannabis compound CBN has the potential to treat age-related neurodegenerative diseases, such as Alzheimer’s, according to new research. Published in Free Radical Biology and Medicine,…
GMP Series #8: Manufacturing Startup Authored By: Michael Sassano and Antonio Guedelha Your journey maneuvering through the start-up phase of Good Manufacturing Practices (GMP) will…
A Generis depois de perder a liderança no ano de 2020, voltou em 2021 a liderar os Titulares de AIMs com maior numero de lançamento…
GMP Series #7: Personnel Recruitment Authored By: Michael Sassano and Antonio Guedelha No matter what you build or which equipment you purchase, your business…
Michael Sassano: GMP Series Part 6 – Quality Assurance Implementation Authored by Michael Sassano Quality Assurance System Implementation The difference between Quality Control (QC)…
Article – Michael Sassano CEO and Chairman Somai Pharmaceuticals: GMP Series #5: ERP Implementations Authors Michael Sassano Antonio Guedelha When tackling your computer systems,…
Michael Sassano and Antonio Guedelha: GMP Series Part 4: Laboratory Set-Up Authored by Michael Sassano and Antonio Guedelha Michael Sassano The laboratory is…
Malta is one step away from legalizing recreational, adult-use cannabis. A legalization bill has been approved in the country’s parliament by 36 votes to 27.…
GMP Series Part 3: Process Equipment Procurement Authored by Michael Sassano and Antonio Guedelha Michael Sassano Also see GMP & Compliance: GMP SERIES #1: “Starting…